Acalculous Cholecystitis: An Unusual Manifestation of Cytomegalovirus Disease in Renal Transplant Recipient

Abstract Full-Text HTML XML Download Download as PDF (Size:30KB) PP. 115-116
DOI: 10.4236/ojneph.2013.32020    3,309 Downloads   5,174 Views  


Background: Common clinical manifestations of cytomegalovirus (CMV) infection include flu-like symptoms with fever, diarrhea, leukopenia, and elevated liver enzymes. Diagnosis is made by detection of the virus by buffy-coat blood culture or by polymerase chain reaction (PCR) analysis. Methods: Here we describe a women renal transplant recipient who presented with acalculous cholecystitis with CMV viremia, anemia and leucopenia tree months after she received a kidney from cadaveric donor. Results: Retrospective analysis of peripheral blood by PCR analysis was positive for CMV DNA. Treatement with Intravenous Ganciclovir was started after diagnosis. The role of cholecystectomy in patients diagnosed as having acalculous cholecystitis associated with systemic CMV disease remains unclear. Conclusions: Because CMV infection is common in transplant patients, the atypical manifestations of CMV should be considered in the differential diagnosis of posttransplant complications. Detection of CMV DNA in the peripheral blood by PCR analysis may help identify these patients.

Cite this paper

M. Allah, N. Bassit, W. Fadili and I. Laouad, "Acalculous Cholecystitis: An Unusual Manifestation of Cytomegalovirus Disease in Renal Transplant Recipient," Open Journal of Nephrology, Vol. 3 No. 2, 2013, pp. 115-116. doi: 10.4236/ojneph.2013.32020.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] P. L. Hibberd and D. R. Snydman, “Cytomegalovirus Infection in Organ Transplant Recipients,” Infectious Disease Clinics of North America, Vol. 9, No. 4, 1995, pp. 863-877.
[2] P. L. Hibbered, N. E. Tolkoff-Rubin, D. Conti, et al., “Pre-Emptive Ganciclovir Therapy to Prevent Cytomegalovirus Disease in Cytomegalovirus Antibody-Positive Renal Transplant Recipients: A Randomized Controlled Trial,” Annals of Internal Medicine, Vol. 123, No. 1, 1995, pp. 18-26. doi:10.7326/0003-4819-123-1-199507010-00002
[3] A. Moudgil, S. C. Jordan, et al., “Ureteritis and Cholecystitis: Two Unusual Manifestations of Cytomegalovirus Disease in Renal Transplant Recipients,” Transplantation, Vol. 64, 1997, pp. 1071-1073. doi:10.1097/00007890-199710150-00021
[4] N. Bagchi, P. Kumar, et al., “Cytomegalovirus Cholecystitis: A Case Report,” Transplantation, Vol. 75, 2003, pp. 1918-1919. doi:10.1097/01.TP.0000065804.62470.52
[5] D. M. McMullan, O. H. Frazier, et al., “Cytomegalovirus Cholecystitis in a Heart Transplant Recipient,” Transplantation Proceedings, Vol. 34, No. 4, 2002, pp. 12711272. doi:10.1016/S0041-1345(02)02753-7
[6] A. Franco, J. Olivares, et al., “Perforation of the Acalculous Gallbladder in a Renal Transplant Recipient with CMV Infection,” Nefrologia, Vol. 26, 2006, pp. 619-622
[7] M. Drage, J. Watson, et al., “Acute Cytomegalovirus Cholecystitis Following Renal Transplantation,” American Journal of Transplantation, Vol. 9, No. 5, 2009, pp. 1249-1252. doi:10.1111/j.1600-6143.2009.02607.x
[8] M. D. Adolf, S. N. Bass, S. K. Lee, et al., “Cytomegaloviral Acalculous Cholecystitis in Acquired Immuno Deficiency Syndrome Patients,” Annals of Surgery, Vol. 59, 1993, p. 69.
[9] M. A. Jacobson and J. Mills, “Serious Cytomegalovirus Disease in the Acquired Immunodeficiency Syndrome (AIDS),” Annals of Internal Medicine, 1988, Vol. 108, No. 4, pp. 585-594. doi:10.7326/0003-4819-108-4-585

comments powered by Disqus

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.